Business & Finance

IPURE is among first to win official approval for e-liquid manufacturing in China

1 Mins read

Shenzhen IPURE Biotechnology Co., Ltd. has been approved as one of the first vape companies to gain the new e-liquid manufacturing production license in China.

IPURE is an internationally-recognised e-liquid and flavour concentrate manufacturer which provides one-stop innovative solutions for vaping industry and OEM/ODM clients around the world.

It is also a modern high-tech enterprise, integrating R&D, production and sales.

IPURE has become a key supplier to more than 300 famous vape brands worldwide and is proud of the reputation it has gained for high quality products and excellent customer satisfaction.

It has passed inspections to gain many factory and safety control system certifications including the GMP, ISO9001 and ISO22000.

IPURE has already established two independent industrial zones, with a manufacturing area of over 16,000m².

Fully-automated and highly sophisticated production lines means that IPURE can easily reach a daily capacity of 20 tons of bulk e-liquid.

In addition, the IPURE Research Institute and Compliance Center has been set up to ensure the safety and compliance of e-liquid.

The CNAS-Grade lab also enables IPURE to guarantee a consistently high standard of e-liquid and it is proud to have entered the era of IPURE 3.0 which has compliance and intelligence at its core.

Get access to every edition of Vapouround